SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Sanara MedTech Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$33.14−0.02 (-0.06%)

Close on Oct 19, 2026

Market cap: $287.08M
P/E (TTM): –
Dividend yield: –

Sanara MedTech Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Depreciation & Amortization	3.95	4.92	3.68	2.37	0.60	0.29	0.12	0.08	0.08	0.06	0.06	0.06	0.05	0.06	0.47	0.47
Stock-Based Compensation	5.15	4.44	3.44	2.70	2.67	1.40	0	–	–	–	–	–	–	0.53	0	–
Deferred Income Taxes	–	–	–	-5.84	–	–	–	–	–	–	–	–	–	0	0	–
Change in Accounts Receivable	-0.11	-4.51	-1.82	-2.25	-0.70	-0.96	-0.32	-0.61	0.06	0.50	-0.02	0.08	0.04	-0.08	-0.38	0.42
Change in Inventory	-1.78	1.44	-1.55	-0.52	-1.15	-0.72	–	-0.26	0.42	0.09	0.14	0.18	0.10	0.16	-0.13	0.16
Change in Accounts Payable	0.81	-0.42	0.53	-0.30	0.17	-0.07	-0.07	-0.17	0.03	0.02	0.03	0.02	-0.07	0.20	-0.31	-0.05
Operating Cash Flow	6.79	-0.02	-3.25	-5.55	-4.81	-4.03	-2.17	0.28	-0.14	0.41	-1.20	-1.69	-1.82	-1.23	-0.34	-1.49
Capital Expenditures	-4.63	-0.21	-0.27	-0.15	-0.17	-0.54	-0.18	-0.01	-0.04	0.00	-0.01	-0.01	-0.03	–	–	–
Acquisitions	–	–	-9.94	-2.52	–	–	–	–	–	–	–	–	–	–	–	0.10
Sale of Property, Plant & Equipment	0.06	–	0.00	0.00	–	0	0.00	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-15	-6.61	-10	-3.51	-5.28	-2.74	-1.20	-0.01	-0.09	0.00	-0.01	-0.01	-0.03	0.37	-1.34	-0.21
Share Repurchases	–	–	–	–	–	0	0.00	–	–	–	–	–	–	–	–	–
Stock Issued	–	–	–	–	–	–	–	–	–	–	–	–	–	0.10	0.96	0.34
Debt Issued	–	–	–	–	–	0.58	–	–	–	–	–	–	–	–	–	–
Other Financing Activities	-0.55	-0.13	-0.14	-0.41	-0.44	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	8.89	17	9.64	-0.63	28	0.62	9.80	0	-0.14	0.24	0.87	2.17	1.85	0.90	1.63	1.76
Net Change in Cash	0.70	11	-3.81	-9.69	18	-6.16	6.44	–	–	–	–	–	–	0.04	-0.05	0.06
Free Cash Flow	2.16	-0.23	-3.51	-5.70	-4.99	-4.58	-2.35	0.27	-0.18	0.41	-1.21	-1.69	-1.85	–	–	–
Income Taxes Paid	0.05	0.04	–	–	–	0	0	0	0	0	0	0	0	0	0	–
Interest Paid	3.35	1.58	0.28	0.00	0.00	0	0.04	0	0.01	0.05	0.09	0.10	0.13	0.03	0.17	0.02

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 93.0%
Operating margin: 7.7%
Net margin: -29.2%
Return on equity, FY2025: -165.7%

Financial strength

Current ratio: 2.58
Debt to equity: 5.85
Debt to assets: 67.2%
Cash to current liabilities: 123.4%

Valuation

P/E ratio: –
Price to sales: 2.61
Price to book: 36.14
Dividend yield: –